Skip to main content
Erschienen in: Intensive Care Medicine 10/2017

Open Access 23.03.2016 | Editorial

Is the literature inconclusive about the harm from HES? No

verfasst von: Christian J. Wiedermann, Rinaldo Bellomo, Anders Perner

Erschienen in: Intensive Care Medicine | Ausgabe 10/2017

Einloggen, um Zugang zu erhalten

Excerpt

Colloid solutions may be more effective than crystalloid solutions in expanding the intravascular space, which may result in improved hemodynamics and reduced tissue edema. Whether this is clinically important is unknown. Despite lack of evidence of overall benefit in terms of clinical or patient-important outcome measures, hydroxyethyl starch (HES), an artificial colloid solution, has been used in a variety of clinical settings to treat hypovolemia including during surgery, after trauma and burns, in sepsis, and in critically ill patients. As we will outline below, HES has clear side effects based on well-described pathophysiologic pathways resulting in worse outcome in critically ill patients. …
Literatur
1.
Zurück zum Zitat Mutter TC, Ruth CA, Dart AB (2013) Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev 7:CD007594 Mutter TC, Ruth CA, Dart AB (2013) Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev 7:CD007594
2.
Zurück zum Zitat Myburgh JA, Finfer S, Bellomo R et al (2012) Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 367:1901–1911CrossRefPubMed Myburgh JA, Finfer S, Bellomo R et al (2012) Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 367:1901–1911CrossRefPubMed
3.
Zurück zum Zitat Haase N, Perner A, Hennings LI et al (2013) Hydroxyethyl starch 130/0.38–0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis. BMJ 346:f839CrossRefPubMedPubMedCentral Haase N, Perner A, Hennings LI et al (2013) Hydroxyethyl starch 130/0.38–0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis. BMJ 346:f839CrossRefPubMedPubMedCentral
4.
5.
Zurück zum Zitat Wilkes MM, Navickis R (2014) Postoperative renal replacement therapy after hydroxyethyl starch infusion: a meta-analysis of randomised trials. Neth J Crit Care 18:4–9 Wilkes MM, Navickis R (2014) Postoperative renal replacement therapy after hydroxyethyl starch infusion: a meta-analysis of randomised trials. Neth J Crit Care 18:4–9
6.
Zurück zum Zitat Bellmann R, Feistritzer C, Wiedermann CJ (2012) Effect of molecular weight and substitution on tissue uptake of hydroxyethyl starch: a meta-analysis of clinical studies. Clin Pharmacokinet 51:225–236CrossRefPubMed Bellmann R, Feistritzer C, Wiedermann CJ (2012) Effect of molecular weight and substitution on tissue uptake of hydroxyethyl starch: a meta-analysis of clinical studies. Clin Pharmacokinet 51:225–236CrossRefPubMed
7.
Zurück zum Zitat Wiedermann CJ, Joannidis M (2014) Accumulation of hydroxyethyl starch in human and animal tissues: a systematic review. Intensive Care Med 40:160–170CrossRefPubMed Wiedermann CJ, Joannidis M (2014) Accumulation of hydroxyethyl starch in human and animal tissues: a systematic review. Intensive Care Med 40:160–170CrossRefPubMed
8.
Zurück zum Zitat Claus RA, Sossdorf M, Hartog C et al (2010) The effects of hydroxyethyl starch on cultured renal epithelial cells. Anesth Analg 110:300–301CrossRefPubMed Claus RA, Sossdorf M, Hartog C et al (2010) The effects of hydroxyethyl starch on cultured renal epithelial cells. Anesth Analg 110:300–301CrossRefPubMed
9.
Zurück zum Zitat Haase N, Wetterslev J, Winkel P, Perner A (2013) Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial. Intensive Care Med 39:2126–2134CrossRefPubMed Haase N, Wetterslev J, Winkel P, Perner A (2013) Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial. Intensive Care Med 39:2126–2134CrossRefPubMed
10.
Zurück zum Zitat Rasmussen KC, Johansson PI, Højskov M et al (2014) Hydroxyethyl starch reduces coagulation competence and increases blood loss during major surgery: results from a randomized controlled trial. Ann Surg 259:249–254CrossRefPubMed Rasmussen KC, Johansson PI, Højskov M et al (2014) Hydroxyethyl starch reduces coagulation competence and increases blood loss during major surgery: results from a randomized controlled trial. Ann Surg 259:249–254CrossRefPubMed
11.
Zurück zum Zitat Kancir AS, Johansen JK, Ekeloef NP et al (2015) The effect of 6 % hydroxyethyl starch 130/0.4 on renal function, arterial blood pressure, and vasoactive hormones during radical prostatectomy: a randomized controlled trial. Anesth Analg 120:608–618CrossRefPubMed Kancir AS, Johansen JK, Ekeloef NP et al (2015) The effect of 6 % hydroxyethyl starch 130/0.4 on renal function, arterial blood pressure, and vasoactive hormones during radical prostatectomy: a randomized controlled trial. Anesth Analg 120:608–618CrossRefPubMed
12.
Zurück zum Zitat Navickis RJ, Haynes GR, Wilkes MM (2012) Effect of hydroxyethyl starch on bleeding after cardiopulmonary bypass: a meta-analysis of randomized trials. J Thorac Cardiovasc Surg 144:223–230CrossRefPubMed Navickis RJ, Haynes GR, Wilkes MM (2012) Effect of hydroxyethyl starch on bleeding after cardiopulmonary bypass: a meta-analysis of randomized trials. J Thorac Cardiovasc Surg 144:223–230CrossRefPubMed
13.
14.
Zurück zum Zitat Hartog CS, Reuter D, Loesche W et al (2011) Influence of hydroxyethyl starch (HES) 130/0.4 on hemostasis as measured by viscoelastic device analysis: a systematic review. Intensive Care Med 37:1725–1737CrossRefPubMed Hartog CS, Reuter D, Loesche W et al (2011) Influence of hydroxyethyl starch (HES) 130/0.4 on hemostasis as measured by viscoelastic device analysis: a systematic review. Intensive Care Med 37:1725–1737CrossRefPubMed
15.
Zurück zum Zitat Perner A, Haase N, Guttormsen AB et al (2012) Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis. N Engl J Med 367:124–134CrossRefPubMed Perner A, Haase N, Guttormsen AB et al (2012) Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis. N Engl J Med 367:124–134CrossRefPubMed
16.
Zurück zum Zitat Perel P, Roberts I, Ker K (2013) Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2:CD000567 Perel P, Roberts I, Ker K (2013) Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2:CD000567
17.
Zurück zum Zitat Zarychanski R, Abou-Setta AM, Turgeon AF et al (2013) Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA 309:678–688CrossRefPubMed Zarychanski R, Abou-Setta AM, Turgeon AF et al (2013) Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA 309:678–688CrossRefPubMed
18.
Zurück zum Zitat Annane D, Siami S, Jaber S et al (2013) Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA 310:1809–1817CrossRefPubMed Annane D, Siami S, Jaber S et al (2013) Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA 310:1809–1817CrossRefPubMed
19.
Zurück zum Zitat Savović J, Jones HE, Altman DG et al (2012) Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Ann Intern Med 157:429–438CrossRefPubMed Savović J, Jones HE, Altman DG et al (2012) Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Ann Intern Med 157:429–438CrossRefPubMed
20.
Metadaten
Titel
Is the literature inconclusive about the harm from HES? No
verfasst von
Christian J. Wiedermann
Rinaldo Bellomo
Anders Perner
Publikationsdatum
23.03.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Intensive Care Medicine / Ausgabe 10/2017
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-016-4275-x

Weitere Artikel der Ausgabe 10/2017

Intensive Care Medicine 10/2017 Zur Ausgabe

Focus Editorial

Focus on ARDS

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.